Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Gong

Showing results (161-170 of 231) with videos related to

Pageof 24
Sort By:
Chest|April 5, 2021
Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill AdultsJin H Han, Adit A Ginde, Samuel M Brown, et al.
Influenza and Other Respiratory Viruses|September 26, 2023
Modifiable in-hospital factors for 12-month global cognition, post-traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID-19Jin H Han, James C Jackson, Onur M Orun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND)Leora R Feldstein, Wesley H Self, Jill M Ferdinands, et al.
Circulation|June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled TrialScott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.
The Journal of Infectious Diseases|May 20, 2021
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness EstimatesLeora R Feldstein, Jill M Ferdinands, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative StudyCarlos G Grijalva, Leora R Feldstein, H Keipp Talbot, et al.
Vaccine|August 11, 2021
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020Kelsey L Lytle, Sean P Collins, Leora R Feldstein, et al.
The New England Journal of Medicine|January 23, 2023
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension, Nathan I Shapiro, Ivor S Douglas, et al.
Chest|November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.
The New England Journal of Medicine|May 23, 2017
Angiotensin II for the Treatment of Vasodilatory ShockAshish Khanna, Shane W English, Xueyuan S Wang, et al.
Pageof 24

Showing results (161-170 of 231) with videos related to

Sort By:
Pageof 24
Chest|April 5, 2021
Effect of Early High-Dose Vitamin D3 Repletion on Cognitive Outcomes in Critically Ill AdultsJin H Han, Adit A Ginde, Samuel M Brown, et al.
Influenza and Other Respiratory Viruses|September 26, 2023
Modifiable in-hospital factors for 12-month global cognition, post-traumatic stress disorder symptoms, and depression symptoms in adults hospitalized with COVID-19Jin H Han, James C Jackson, Onur M Orun, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 25, 2020
Incorporating Real-time Influenza Detection Into the Test-negative Design for Estimating Influenza Vaccine Effectiveness: The Real-time Test-negative Design (rtTND)Leora R Feldstein, Wesley H Self, Jill M Ferdinands, et al.
Circulation|June 25, 2023
Effect of the P-Selectin Inhibitor Crizanlizumab on Survival Free of Organ Support in Patients Hospitalized for COVID-19: A Randomized Controlled TrialScott D Solomon, Charles J Lowenstein, Ankeet S Bhatt, et al.
The Journal of Infectious Diseases|May 20, 2021
Modeling the Impacts of Clinical Influenza Testing on Influenza Vaccine Effectiveness EstimatesLeora R Feldstein, Jill M Ferdinands, Wesley H Self, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Influenza Vaccine Effectiveness for Prevention of Severe Influenza-Associated Illness Among Adults in the United States, 2019-2020: A Test-Negative StudyCarlos G Grijalva, Leora R Feldstein, H Keipp Talbot, et al.
Vaccine|August 11, 2021
Influenza vaccine acceptance and hesitancy among adults hospitalized with severe acute respiratory illnesses, United States 2019-2020Kelsey L Lytle, Sean P Collins, Leora R Feldstein, et al.
The New England Journal of Medicine|January 23, 2023
Early Restrictive or Liberal Fluid Management for Sepsis-Induced Hypotension, Nathan I Shapiro, Ivor S Douglas, et al.
Chest|November 18, 2023
Symptoms and Impaired Quality of Life After COVID-19 Hospitalization: Effect of Therapeutic Heparin in Non-ICU Patients in the Accelerating COVID-19 Therapeutic Interventions and Vaccines 4 Acute Trial: Effect on 3-Month Symptoms and Quality of LifeYonatan Y Greenstein, Kinsley Hubel, Joshua Froess, et al.
The New England Journal of Medicine|May 23, 2017
Angiotensin II for the Treatment of Vasodilatory ShockAshish Khanna, Shane W English, Xueyuan S Wang, et al.
Pageof 24